Joseph Susa: Response to the FDA Approval of Abbvie's New Antibody Conjugated Drug - OncoDaily
Joseph Susa: Response to the FDA Approval of Abbvie's New Antibody Conjugated Drug / AbbVie, cancer, FDA, Jae-Cheol Jo, Joseph Susa, OncoDaily, Oncology, Sang
oncodaily.com